Progression to androgen independence remains the main problem that impacts on survival and quality of life in prostate cancer patients. We have investigated the potency of tributyrin, an orally available prodrug of butyrate, to induce growth arrest, differentiation and apoptosis in LNCaP, PC-3 and T
Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties
โ Scribed by Akira Tanaka; Kaoru Miyamoto; Hisayuki Matsuo; Keishi Matsumoto; Hiroki Yoshida
- Book ID
- 115930711
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 445 KB
- Volume
- 363
- Category
- Article
- ISSN
- 0014-5793
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
BACKGROUND. Androgen-independent growth leads to progressive prostate cancer after androgen-ablation therapy. This may be caused by altered specificity of the androgen receptor (AR), by ligand-independent stimulation of the AR, or by paracrine growth modulation by neuropeptides secreted by neuroendo
Polypeptide growth factors are positive and negative regulators of prostatic growth and function, and many positive regulators of growth in the prostate have been extensively studied. However, very few inhibitors of prostate cell proliferation have been identified. We have isolated a unique 18-kDa s
Tumor expansion is dependent on angiogenesis, which is regulated by peptide growth factors of which vascular endothelial growth factor (VEGF) is one of the most selective and potent. VEGF expression is regulated by steroid hormones in a number of systems, including T47-D human breast cancer cells in